As of 2025-07-15, the Intrinsic Value of Preveceutical Medical Inc (PREV.CN) is -0.04 CAD. This PREV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.04 CAD, the upside of Preveceutical Medical Inc is -216.17%.
Based on its market price of 0.04 CAD and our intrinsic valuation, Preveceutical Medical Inc (PREV.CN) is overvalued by 216.17%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.04 - -0.04 | -0.04 | -216.17% |
| DDM - Stable | (0.03) - (0.09) | (0.06) | -263.5% |
| DDM - Multi | (0.02) - (0.05) | (0.03) | -185.7% |
| Market Cap (mil) | 19.97 |
| Beta | 0.13 |
| Outstanding shares (mil) | 570.65 |
| Enterprise Value (mil) | 24.57 |
| Market risk premium | 5.10% |
| Cost of Equity | 9.48% |
| Cost of Debt | 5.00% |
| WACC | 8.66% |